These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3110540

  • 1. Ascorbate regulation of collagen biosynthesis in Ehlers-Danlos syndrome, type VI.
    Dembure PP, Janko AR, Priest JH, Elsas LJ.
    Metabolism; 1987 Jul; 36(7):687-91. PubMed ID: 3110540
    [Abstract] [Full Text] [Related]

  • 2. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
    Yeowell HN, Walker LC, Marshall MK, Murad S, Pinnell SR.
    Arch Biochem Biophys; 1995 Aug 20; 321(2):510-6. PubMed ID: 7646078
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Abnormal properties of collagen lysyl hydroxylase from skin fibroblasts of siblings with hydroxylysine-deficient collagen.
    Quinn RS, Krane SM.
    J Clin Invest; 1976 Jan 20; 57(1):83-93. PubMed ID: 173744
    [Abstract] [Full Text] [Related]

  • 9. Genotyping and prenatal assessment of collagen lysyl hydroxylase deficiency in a family with Ehlers-Danlos syndrome type VI.
    Dembure PP, Priest JH, Snoddy SC, Elsas LJ.
    Am J Hum Genet; 1984 Jul 20; 36(4):783-90. PubMed ID: 6089551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine.
    Yeowell HN, Walker LC, Murad S, Pinnell SR.
    Arch Biochem Biophys; 1997 Nov 01; 347(1):126-31. PubMed ID: 9344473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular defects in the Ehlers-Danlos syndrome.
    Pinnell SR.
    J Invest Dermatol; 1982 Jul 01; 79 Suppl 1():90s-92s. PubMed ID: 7086195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biochemical characteristics of Ehlers-Danlos syndrome type VI in a family with one affected infant.
    Krieg T, Feldmann U, Kessler W, Müller PK.
    Hum Genet; 1979 Jan 19; 46(1):41-9. PubMed ID: 429005
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differences between proline and lysine hydroxylations in their inhibition by zinc or by ascorbate deficiency during collagen synthesis in various cell types.
    Anttinen H, Puistola U, Pihlajaniemi T, Kivirikko KI.
    Biochim Biophys Acta; 1981 May 18; 674(3):336-44. PubMed ID: 6263355
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.